NCT06884475

Brief Summary

The aim of this longitudinal study is to evaluate the clinical impact of implantoplasty in the treatment of peri-implantitis, exploring the potential effect of removing compromised implants on periodontal health and its correlation with the presence of titanium particles in the crevicular fluid. In addition, we seek to investigate changes in the peri-implant microbiological profile before and after implantoplasty, allowing a more comprehensive understanding of the effects of this procedure at both the biological and clinical levels, considering microbiological factors and the relationship with titanium, inflammation and peri-implant health. Forty participants diagnosed with peri-implantitis will be selected (n = 20 in each group) to participate in the study. They will be randomly allocated into two groups, according to the treatment to be performed (implantoplasty group and surgical access group for scaling). Using a millimeter-diameter periodontal probe, the initial clinical parameters of patients with periodontal and peri-implant disease will be evaluated. Biofilm and crevicular fluid will then be collected using sterile paper cones from one implant of each patient in all groups at follow-up intervals of 1, 3 and 6 months for subsequent processing and evaluation of the data. The integration of these analyses aims to offer valuable insights to optimize peri-implantitis treatment strategies, aiming at the health and longevity of dental implants.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Apr 2025Jul 2026

First Submitted

Initial submission to the registry

February 18, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 19, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

February 18, 2025

Last Update Submit

March 16, 2026

Conditions

Keywords

Peri-implantitisImplantoplastyTitaniumImmune responseMicrobiotaSurgical access

Outcome Measures

Primary Outcomes (6)

  • Clinical parameters before and after implantoplasty and compare them to surgical access without implantoplasty.

    Plaque index.

    Baseline; 1,3 and 6 months after procedure.

  • Clinical parameters before and after implantoplasty and compare them to surgical access without implantoplasty.

    Bleeding on probing.

    Baseline; 1,3 and 6 months after procedure.

  • Clinical parameters before and after implantoplasty and compare them to surgical access without implantoplasty.

    Probing depth.

    Baseline; 1,3 and 6 months after procedure.

  • Clinical parameters before and after implantoplasty and compare them to surgical access without implantoplasty.

    Clinical insertion level.

    Baseline; 1,3 and 6 months after procedure.

  • Quantity of titanium particles in the crevicular fluid before and after implantoplasty.

    Concentration of Titanium in the peri-implant environment.

    Baseline; 1,3 and 6 months after procedure.

  • To characterize and compare the peri-implant microbiological profile before and after implantoplasty.

    Microbiome.

    Baseline; 1,3 and 6 months after procedure.

Secondary Outcomes (1)

  • Correlation between the presence of titanium particles, microbiological profile and local inflammatory response.

    Baseline; 1,3 and 6 months after procedure.

Study Arms (2)

Implantoplasty: treatment of peri-implantitis.

EXPERIMENTAL

After patient selection, 20 individuals (chosen randomly) will be selected to receive treatment for Peri-implantitis with surgical access and implantoplasty.

Procedure: Implantoplasty

Surgical access: treatment of peri-implantitis.

EXPERIMENTAL

After patient selection, 20 individuals (chosen randomly) will be selected to receive treatment for peri-implantitis with surgical access and debridement without performing implantoplasty.

Procedure: Surgical access

Interventions

Following clinical and radiographic examinations and thorough case planning, surgical procedures were performed under local anesthesia by a operator. After, anesthesia, only surgical access will be performed for debridement without implantoplasty of the affected dental implant.

Surgical access: treatment of peri-implantitis.

Following clinical and radiographic examinations and thorough case planning, surgical procedures were performed under local anesthesia by a operator. After, anesthesia, surgical access will be performed for debridement and implantoplasty of the affected dental implant.

Implantoplasty: treatment of peri-implantitis.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • The following conditions will also be excluded: Pregnancy or lactation; Use of antibiotic or anti-inflammatory medication in the 6 months prior to the study; Presence of systemic diseases that make the surgical procedure impossible; Periodontal treatment including subgingival instrumentation in the 6 weeks prior to the study; Chronic alcohol users; Previous periodontal surgeries in the region of interest; Oral pathologies in the region of interest.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Piracicaba Dental School

Piracicaba, São Paulo, 13414903, Brazil

Location

MeSH Terms

Conditions

Peri-Implantitis

Interventions

Minimally Invasive Surgical Procedures

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Renato Casarin, PhD

    University of Campinas, Brazil

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, supervisor responsible for research

Study Record Dates

First Submitted

February 18, 2025

First Posted

March 19, 2025

Study Start

April 1, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations